A new blood test could detect lung cancer recurrence months before it appears on scans, potentially enabling earlier ...

A prospective study found that a multicancer blood test detected signals across 17 cancer types with 99.64% specificity, but ...

New findings suggest that a blood test can detect circulating tumor DNA (ctDNA), potentially identifying signs of lung cancer ...

Abbott’s next-gen Oncodetect molecular residual disease (MRD) test detects traces of circulating tumor DNA in a patient’s ...

A revolutionary blood test designed to detect more than 50 types of cancer has failed to achieve its main goal in a trial ...

Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients with solid tumors ...

The updates improve upon the option for a first-line screening tool for those who are unable or unwilling to receive the more ...

Learn about a new blood test that could lead to earlier detection and treatment of breast cancer.

A new blood test could diagnose pancreatic cancer much earlier, improving survival rates for people with the disease. A large part of the reason for this poor prognosis is that pancreatic cancer is ...

Singapore blood test CIRRHOClear could help detect liver cirrhosis risk early and prevent liver failure and liver cancer.

Researchers at USC have launched an early-stage clinical trial to investigate whether a blood test could help detect breast ...